The Clorox Company (NYSE:CLX) Shares Acquired by Brookstone Capital Management

Brookstone Capital Management raised its stake in The Clorox Company (NYSE:CLXFree Report) by 0.2% during the second quarter, according to its most recent disclosure with the SEC. The fund owned 100,135 shares of the company’s stock after buying an additional 164 shares during the quarter. Brookstone Capital Management owned approximately 0.08% of Clorox worth $15,820,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Vanguard Group Inc. increased its stake in shares of Clorox by 1.3% during the first quarter. Vanguard Group Inc. now owns 14,685,046 shares of the company’s stock valued at $2,041,661,000 after acquiring an additional 185,012 shares during the period. BlackRock Inc. raised its position in Clorox by 2.1% in the first quarter. BlackRock Inc. now owns 9,463,011 shares of the company’s stock worth $1,497,427,000 after acquiring an additional 195,348 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Clorox by 3.8% during the 1st quarter. Geode Capital Management LLC now owns 2,725,410 shares of the company’s stock valued at $430,349,000 after purchasing an additional 100,920 shares in the last quarter. Stifel Financial Corp raised its holdings in shares of Clorox by 5.1% in the 1st quarter. Stifel Financial Corp now owns 2,583,847 shares of the company’s stock worth $408,878,000 after purchasing an additional 124,644 shares in the last quarter. Finally, Northern Trust Corp boosted its holdings in Clorox by 1.1% during the first quarter. Northern Trust Corp now owns 1,931,351 shares of the company’s stock worth $268,515,000 after buying an additional 21,058 shares in the last quarter. 77.98% of the stock is owned by institutional investors.

Insider Buying and Selling at Clorox

In related news, CFO Kevin B. Jacobsen sold 3,346 shares of the firm’s stock in a transaction on Monday, August 14th. The shares were sold at an average price of $160.82, for a total value of $538,103.72. Following the transaction, the chief financial officer now directly owns 23,224 shares in the company, valued at approximately $3,734,883.68. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.41% of the company’s stock.

Clorox Stock Down 2.2 %

CLX traded down $3.25 during midday trading on Friday, hitting $146.20. 1,703,760 shares of the company’s stock traded hands, compared to its average volume of 1,199,895. The company has a debt-to-equity ratio of 6.38, a current ratio of 0.95 and a quick ratio of 0.59. The company has a market cap of $18.10 billion, a PE ratio of 122.86, a price-to-earnings-growth ratio of 2.13 and a beta of 0.28. The Clorox Company has a one year low of $124.58 and a one year high of $178.21. The stock’s fifty day simple moving average is $155.09 and its 200-day simple moving average is $157.91.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings data on Wednesday, August 2nd. The company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.19 by $0.48. The business had revenue of $2.02 billion during the quarter, compared to analyst estimates of $1.88 billion. Clorox had a net margin of 2.02% and a return on equity of 163.56%. Clorox’s quarterly revenue was up 12.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.93 EPS. As a group, equities analysts anticipate that The Clorox Company will post 5.87 earnings per share for the current fiscal year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 25th. Investors of record on Wednesday, August 9th were issued a $1.20 dividend. This is a positive change from Clorox’s previous quarterly dividend of $1.18. This represents a $4.80 annualized dividend and a yield of 3.28%. The ex-dividend date was Tuesday, August 8th. Clorox’s payout ratio is 403.36%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on CLX shares. StockNews.com upgraded Clorox from a “hold” rating to a “buy” rating in a research report on Friday, September 8th. Barclays lifted their price target on Clorox from $117.00 to $127.00 and gave the stock an “underweight” rating in a research note on Friday, August 4th. Atlantic Securities raised shares of Clorox from an “underweight” rating to a “neutral” rating in a research note on Thursday, August 3rd. Finally, DA Davidson lifted their target price on shares of Clorox from $155.00 to $176.00 and gave the stock a “neutral” rating in a research report on Monday, August 7th. Six investment analysts have rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $150.38.

Check Out Our Latest Research Report on Clorox

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.